Results 81 to 90 of about 526,949 (124)

In vivo evaluation of a novel 18F-labeled PET radioligand for translocator protein 18 kDa (TSPO) in monkey brain. [PDF]

open access: yesEur J Nucl Med Mol Imaging, 2023
Yan X   +11 more
europepmc   +1 more source

Application of 89Zr-DFO*-immuno-PET to assess improved target engagement of a bispecific anti-amyloid-ß monoclonal antibody. [PDF]

open access: yesEur J Nucl Med Mol Imaging, 2023
Stergiou N   +15 more
europepmc   +1 more source

Development of brain-penetrable antibody radioligands for in vivo PET imaging of amyloid-β and tau. [PDF]

open access: yesFront Nucl Med, 2023
Banka V   +6 more
europepmc   +1 more source

Gadolinium-Based Nanoparticles Sensitize Ovarian Peritoneal Carcinomatosis to Targeted Radionuclide Therapy. [PDF]

open access: yesJ Nucl Med, 2023
Garcia-Prada CD   +14 more
europepmc   +1 more source

Imaging Demyelinated Axons After Spinal Cord Injuries with PET Tracer [<sup>18</sup>F]3F4AP. [PDF]

open access: yesJ Nucl Med
Ramos-Torres KM   +14 more
europepmc   +1 more source

Selective PET imaging of CXCR4 using the Al<sup>18</sup>F-labeled antagonist LY2510924. [PDF]

open access: yesEur J Nucl Med Mol Imaging
Spahn MA   +9 more
europepmc   +1 more source

[ 64Cu]Cu-Albumin Clearance Imaging to Evaluate Lymphatic Efflux of Cerebrospinal Space Fluid in Mouse Model. [PDF]

open access: yesNucl Med Mol Imaging, 2022
Sarker A   +9 more
europepmc   +1 more source

Radiosynthesis and preclinical evaluation of a carbon-11 labeled PET ligand for imaging metabotropic glutamate receptor 7. [PDF]

open access: yesAm J Nucl Med Mol Imaging
Li Y   +30 more
europepmc   +1 more source

[123I]CC1: A PARP-Targeting, Auger Electron-Emitting Radiopharmaceutical for Radionuclide Therapy of Cancer. [PDF]

open access: yesJ Nucl Med, 2023
Chan CY   +11 more
europepmc   +1 more source

Antibody-Based PET Imaging of Misfolded Superoxide Dismutase 1 in an Amyotrophic Lateral Sclerosis Mouse Model. [PDF]

open access: yesJ Nucl Med
Rousseau JA   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy